Trustmark Q2 net earnings rises on higher net interest income
Reuters2026/07/28 20:43
Overview
US regional bank's Q2 net income rose 13% yr/yr, with EPS at $1.08
Company's net interest income grew to $168.6 mln
Trustmark repurchased $21.1 mln of shares in Q2 under existing buyback program
Outlook
Trustmark did not provide specific guidance for the current quarter or full year in the press release
Result Drivers
MORTGAGE LOAN SALE - Sale of delinquent and nonaccrual mortgage loans reduced nonperforming assets and increased pre-tax income by $4.2 mln
DEPOSIT GROWTH - Deposits increased $358.7 mln, or 2.3%, from the prior quarter, supporting net interest margin expansion
TECHNOLOGY INVESTMENTS - Core deposit and related systems were converted to new platforms, increasing efficiency and contributing to higher services and fees expense
Company press release: ID:nBw2qyNS9a
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 EPS |
|
$1.08 |
|
Q2 Net Income |
|
$63.50 mln |
|
Q2 Net Interest Income |
|
$168.60 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the banks peer group is "buy."
Wall Street's median 12-month price target for Trustmark Corp is $46.50, about 0.4% above its July 27 closing price of $46.31
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago
Reuters Recommended Reads
July 28 - UMB Financial Q2 revenue rises on loan growth, fee income
July 28 - Auburn National Bancorporation Q2 EPS rises on interest growth
July 28 - Camden National Q2 net income rises on loan growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin's Weirdest Trader Yet? Fly Brain Makes a Profit
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street -- WSJ
NASDAQ TRADE HALT CONTINUES <MAMK.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM